[Pefloxacin as a treatment for nephrotic syndrome caused by minimal glomerular lesions in the adult: promises or deception?].
Moulin
B
B
D000328:Adult; D000368:Aged; D000818:Animals; D000892:Anti-Infective Agents, Urinary / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D016207:Cytokines / Q000378:metabolism; D003864:Depression, Chemical; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009402:Nephrosis, Lipoid / Q000150:complications*; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D015366:Pefloxacin / Q000494:pharmacology / Q000627:therapeutic use*; D015990:Placebo Effect; D051381:Rats; D012075:Remission, Spontaneous; D012636:Secretory Rate / Q000187:drug effects
D000892:Anti-Infective Agents, Urinary; D016207:Cytokines; D015366:Pefloxacin